Bank of America’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Bank of America’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-71,496	Closed	-$1.52M	–	8525
2024 Q1	$1.52M	Buy	71,496 +70,125	+5,115%	+$839K	﹤0.01%	4636
2023 Q4	$13.2K	Sell	1,371 -176	-11%	-$855	﹤0.01%	6870
2023 Q3	$4.02K	Sell	1,547 -778	-33%	-$2.5K	﹤0.01%	7038
2023 Q2	$10.9K	Buy	+2,325	New	+$10.1K	﹤0.01%	6838
2021 Q4	–	Sell	-1,401	Closed	-$11K	–	8780
2021 Q3	$11K	Sell	1,401 -924	-40%	-$7.78K	﹤0.01%	7559
2021 Q2	$18K	Sell	2,325 -19,298	-89%	-$166K	﹤0.01%	7173
2021 Q1	$232K	Buy	+21,623	New	+$253K	﹤0.01%	5927

Bank of America's FUSN Position: Q2 2024 in Review

Bank of America sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 71,496 shares — an estimated $1.52M sold.

Bank of America first reported a position in FUSN in Q1 2021 and held it in 7 quarters. The position peaked at $1.52M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Bank of America reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Bank of America sold 71,496 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $1.52M.
Bank of America first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2021 and held it in 7 quarters.
Bank of America's Fusion Pharmaceuticals Inc. Common Shares position peaked at $1.52M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.